Navigation and service

Publications in 2012

Authors from the Paul-Ehrlich-Institut are highlighted in bold face type. Where online abstracts or full texts are available of the publications, there is a link to these texts.

Alessandri S, Sancho A, Vieths S, Mills CE, Wal JM, Shewry PR, Rigby N, Hoffmann-Sommergruber K (2012): High-throughput NMR assessment of the tertiary structure of food allergens.
PLoS One 7: e39785.
Online-Abstract

Ammar I, Gogol-Döring A, Miskey C, Chen W, Cathomen T, Izsvák Z, Ivics Z (2012): Retargeting transposon insertions by the adeno-associated virus Rep protein.
Nucleic Acids Res 40: 6693-6712.
Online-Abstract

Anliker B, Renner M, Schweizer M (2012): Insertionsonkogenese bei der Gentherapie monogenetischer Erbkrankheiten.
Bulletin zur Arzneimittelsicherheit 3: 22-26.
Text

Aye CC, Toda M, Morohoshi, Ono SJ (2012): Identification of genes and proteins specifically regulated by costimulation of mast cell Fcε Receptor I and chemokine receptor 1.
Exp Mol Pathol 92: 267-274.
Online-Abstract

Bache C, Spreitzer I, Becker B, Loeschner B, Rosskopf U, Hanschmann KM, Schwanig M, Schneider CK, Lieb B, Montag T (2012): Bordetella Pertussis Toxin does not induce the release of pro-inflammatory cytokines in human whole blood.
Med Microbiol Immunol 201: 327-335.
Online-Abstract

Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, Lasitschka F, Kim B, König R, Fackler OT, Keppler OT (2012): SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.
Nat Med 18: 1682-1687.
Online-Abstract

Balks E, Wolf C, Loessner H, Werner E: Towards in Vitro Potency Testing of Inactivated Erysipelas Vaccines.
In: Jungbäck C (Hrsg.), Potency Testing of Veterinary Vaccines for Animals: The Way From in Vivo to in Vitro. Basel: Karger, 2012. S. 37-44 ISBN 978-3-8055-9892-7
(Dev Biol ; 134)

Ballmer-Weber BK, Skampstrup Hansen K, Sastre J, Andersson K, Bätscher I, Ostling J, Dahl L, Hanschmann KM, Holzhauser T, Poulsen LK, Lidholm J, Vieths S (2012): Component-resolved in vitro diagnosis of carrot allergy in three different regions of Europe.
Allergy 67: 758-766.
Online-Abstract

Bartel D, Führer F, Vieths S (2012): Staatliche Chargenprüfung von Allergenpräparaten.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 358-362.
Text

Baylis SA, Gärtner T, Nick S, Ovemyr J, Blümel J (2012): Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States.
Vox Sang 103: 89-90.

Baylis SA, Koc Ö, Nick S, Blümel J (2012): Widespread distribution of hepatitis E virus in plasma fractionation pools.
Vox Sang 102: 182-183.

Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW, Collaborative Study Group (2012): Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Vox Sang 102: 204-211.
Online-Abstract

Behrensdorf-Nicol H, Bonifas U, Böhl L, Krämer B, Weißer K (2012): Methods for the functional in vitro characterization of tetanus neurotoxin and toxoids.
ALTEX Proceedings: 121-125.

Behrensdorf-Nicol H, Bonifas U, Böhl L, Krämer B, Weißer K (2012): A combined in vitro assay taking into account binding and enzymatic activity allows sensitive detection of active tetanus neurotoxin in vaccines.
ATLA 40: A4-A5.

Bittmann I, Mihica D, Plesker R, Denner J (2012): Expression of porcine endogenous retroviruses (PERV) in different organs of a pig.
Virology 433: 329-336.
Online-Abstract

Blümel J, Rinckel LA, Lee DC, Roth NJ, Baylis SA (2012): Inactivation and neutralization of parvovirus B19 Genotype 3.
Transfusion 52: 1490-1497.
Online-Abstract

Buchholz CJ, Sanzenbacher R, Schüle S (2012): The European hospital exemption clause-new option for gene therapy?.
Hum Gene Ther 23: 7-12.
Online-Abstract

Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nübling CM (2012): First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA.
J Clin Virol 55: 303-309.
Online-Abstract

Chudy M, Weber-Schehl M, Pichl L, Jork C, Kress J, Heiden M, Funk MB, Nübling CM (2012): Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
Transfusion 52: 431-439.
Online-Abstract

Cußler K, Schwedinger E (2012): Nebenwirkungen nach Impfung von Deutschen Pinschern.
DTBl: 1715-1716.
Volltext

Cußler K, Schwedinger E, Hoffmann A: Die Abteilung Veterinärmedizin am Paul-Ehrlich-Institut: Ein Jahrhundert regulatorische Forschung.
In: Schäffer J (Hrsg.), Die Entwicklung des öffentlichen Veterinärwesens. Gießen: DVG, 2012. S. 218-220

Cußler K, Schwedinger E, Kirsch K, Wilke A (2012): Missgeschick mit schmerzhaften Folgen - Nadelstichverletzungen und Fehlinjektionen beim Menschen.
DTBl: 804-807.
Volltext

Denner J, Tönjes RR (2012): Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.
Clin Microbiol Rev 25: 318-343.
Online-Abstract

Denner J, Tönjes RR (2012): Berlin Symposium on Xenotransplantation, German DFG-Transregio Research Group Xenotransplantation (FOR 535) together with the 14th Minisymposium Xenotransplantation of the German Working Group Xenotransplantation (DAX), June 9-10, 2011, Robert Koch Institute, Berlin.
Xenotransplantation 19: 2-22.

Dudareva-Vizule S, Koch J, An der Heiden M, Oberle D, Keller-Stanislawski B, Wichmann O (2012): Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.
Hum Vaccin Immunother 8: [Epub ahead of print].
Online-Abstract

Englert L, May S, Kaul S, Vieths S (2012): Die Therapieallergene-Verordnung - Hintergrund und Auswirkungen.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 351-357.
Text

Etscheid M, Breitner-Ruddock S, Gross S, Hunfeld A, Seitz R, Dodt J (2012): Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products.
Vox Sang 102: 40-46.
Online-Abstract

Etscheid M, Dodt J: Hyaluronan-binding protease/Factor VII activating protease.
In: Barrett AJ, Rawlings ND, Woessner JF (Hrsg.), Handbook of Proteolytic Enzymes. 3. Aufl. London: Academic Press, 2012. S. 693

Etscheid M, Muhl L, Pons D, Jukema JW, König H, Kanse SM (2012): The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Thromb Res 130: 935-941.
Online-Abstract

Funk MB, Guenay S, Lohmann A, Henseler O, Heiden M, Hanschmann KM, Keller-Stanislawski (2012): Benefit of transfusion-related acute lung injury risk-minimization measures - German haemovigilance data (2006-2010).
Vox Sang 102: 317-323.
Online-Abstract

Funk M, Lohmann A, Keller-Stanislawski B (2012): Erhöhte Melderate von schweren hämolytischen Reaktionen nach der intravenösen Gabe von Immunglobulinen.
Bulletin zur Arzneimittelsicherheit 3: 15-17.
Text

Garrels W, Ivics Z, Kues WA (2012): Precision genetic engineering in large mammals.
Trends Biotechnol 30: 386-393.
Online-Abstract

Geppert T, Bauer S, Hiss JA, Conrad E, Reutlinger M, Schneider P, Weisel M, Pfeiffer B, Altmann KH, Waibler Z, Schneider G (2012): Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions.
Angew Chem Int Ed Engl 51: 258-261.
Online-Abstract

Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B (2012): Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
J Allergy Clin Immunol Aug 23 [Epub ahead of print].
Online-Abstract

Gruhle S, Sauter M, Szalay G, Ettischer N, Kandolf R, Klingel K (2012): The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression.
Basic Res Cardiol 107: 287.
Online-Abstract

Gürtler L, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H (2012): Arbonematoden – durch Arthropoden übertragbare Nematoden-Infektionen.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 1044-1056.
Text

Gürtler L, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H (2012): XMRV ist nicht human-pathogen und hat keine Bedeutung für die Sicherheit von Blut und Blutprodukten.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 1057-1060.
Text

Hahn N, Heiden M, Seitz R, Salge-Bartels U (2012): Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
J Cancer Res Clin Oncol 138: 695-703.
Online-Abstract

Hartmann J, Tran TV, Kaudeer J, Oberle K, Herrmann J, Quagliano I, Abel T, Cohnen A, Gatterdam V, Jacobs A, Wollscheid B, Tampé R, Watzl C, Diefenbach A, Koch J (2012): The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.
J Biol Chem 287: 31527-31539.
Online-Abstract

Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC (2012): Guillain-Barré-Syndrom nach Exposition mit Influenza.
Nervenarzt 83: 714-730.
Online-Abstract

Hergert P, Tönjes RR: Rechtliche Grundlagen. Kap. 1.5. Genehmigung von Gewebezubereitungen nach § 21a AMG / Kap. 1.6. Pflichten nach Erhalt einer Genehmigung nach § 21a AMG.
In: Jerosch J, Katthagen BD, Pruß A (Hrsg.), Knochentransplantation - Knochenbank und klinische Anwendung von Bankknochen. Köln: Deutscher Ärzte-Verlag, 2012. S. 9-12 ISBN 978-3-7691-0623-7

Heymans L, Weisser K (2012): Risiken der intravitrealen Anwendung von Bevacizumab (Avastin).
Bulletin zur Arzneimittelsicherheit 3: 3-12.
Text

Hlavaty J, Petznek H, Holzmüller H, Url A, Jandl G, Berger A, Salmons B, Günzburg WH, Renner M (2012): Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.
PLoS One 7: e40611.
Text

Hoffmann A, Schwedinger E, Werner G, Cußler K (2012): Pharmakovigilanzreport Tierimpfstoffe: Analyse der im Jahr 2011 im Paul-Ehrlich-Institut eingegangenen Meldungen.
DTBl: 1554-1559.
Volltext

Holloway C, Mueller-Berghaus J, Lima BS, Lee SL, Wyatt JS, Nicholas JM, Crommelin DJ (2012): Scientific considerations for complex drugs in light of established and emerging regulatory guidance.
Ann N Y Acad Sci 1276: 26-36.
Online-Abstract

Ilchmann A, Krause M, Heilmann M, Burgdorf S, Vieths S, Toda M (2012): Impact of culture medium on maturation of bone marrow-derived murine dendritic cells via the aryl hydrocarbon receptor.
Mol Immunol 51: 42-50.
Online-Abstract

Izsvak Z, Ivics Z: Sleeping Beauty transposon based gene therapy.
In: Cohen-Hagenauer O (Hrsg.), Clinical Gene Transfer - State Of The Art (The CliniBook). Paris: EDK, 2012. S. 284-289

Jakel V, Cußler K, Hanschmann KM, Truyen U, König M, Kamphuis E, Duchow K (2012): Vaccination against Feline Panleukopenia: Implication from a field study in kittens.
BMC Veterinary Research 8: 62.
Text

Javaloyes G, Goikoetxea MJ, García Nuñez I, Aranda A, Sanz ML, Blanca M, Diaz Perales A, da Souza J, Esparza I, Del Pozo V, Blazquez AB, Scheurer S, Vieths S, Ferrer M (2012): Pru p 3 acts as a strong sensitizer for peanut allergy in Spain.
J Allergy Clin Immunol 130: 1432-1434.e3.

Javaloyes G, Goikoetxea MJ, García Nuñez I, Sanz ML, Blanca M, Scheurer S, Vieths S, Ferrer M (2012): Performance of different in vitro techniques in the molecular diagnosis of peanut allergy.
J Investig Allergol Clin Immunol 22: 508-513.
Online-Abstract

Jungbäck C: Potency Testing of Veterinary Vaccines for Animals: The Way From in Vivo to in Vitro : International Scientific Workshop, Langen, December 2010: Proceedings.
Basel ; Freiburg [u.a.]: Karger, 2012. IX, 164 S. : Ill., graph. Darst. ISBN 978-3-8055-9892-7
(Developments in Biologicals ; 134)

Kamphuis E, Hanschmann KM, Meyer H, Göpfert C, Krämer B, Cussler K (2012): Potency estimation of vaccine batches remains unaffected by anesthesia for intracerebral injection.
Biologicals 6: 451-455.
Online-Abstract

Kamphuis E, Meyer H, Göpfert C, Schildger H, Hanschmann KM, Krämer B, Duchow K (2012): Rabies Vaccines for Human Use: Potency Testing Without Mouse Challenge.
ALTEX Proceedings: 215-219.

Kanse SM, Declerck PJ, Ruf W, Broze G, Etscheid M (2012): Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.
Arterioscler Thromb Vasc Biol 32: 427-433.
Online-Abstract

Kanse SM, Gallenmueller A, Zeerleder S, Stephan F, Rannou O, Etscheid M, Lochnit G, Krueger M, Huber-Lang M (2012): Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.
J Immunol 188: 2858-2865.
Online-Abstract

Kasonta R, Sauter-Louis C, Holsteg M, Duchow K, Cussler K, Bastian M (2012): Effect of the vaccination scheme on PregSure®BVD induced alloreactivity and the incidence of Bovine Neonatal Pancytopenia.
Vaccine 30: 6649-6655.
Online-Abstract

Keller-Stanislawski B, Streit R, Paeschke N (2012): Signaldetektion und -analyse.
Bulletin zur Arzneimittelsicherheit 3: 24-29.
Text

Kirsch K, Schwedinger E, Cußler K (2012): Das feline Injektionsstellen-assoziierte Sarkom.
DTBl: 1252-1257.

Kloft N, Neukirch C, von Hoven G, Bobkiewicz W, Weis S, Boller K, Husmann M (2012): A subunit of Eukaryotic Translation Initiation Factor 2 alpha-Phosphatase (CreP/PPP1R15B), regulates membrane traffic.
J Biol Chem 287: 35299-35317.
Online-Abstract

Klug B, Celis P, Carr M, Reinhardt J (2012): Regulatory structures for gene therapy medicinal products in the European Union.
Methods Enzymol 507: 337-354.
Online-Abstract

Klug B, Reinhardt J, Robertson J: Current Status of Regulations for DNA Vaccines.
In: Thalhamer J, Weiss R, Scheiblhofer S (Hrsg.), Gene Vaccines. Wien: Springer, 2012. S. 285-295

Kneissl S, Abel T, Rasbach A, Brynza J, Schneider-Schaulis J, Buchholz CJ (2012): Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
PLoS One 7: e46667.
Text

Kopietz F, Jaguva Vasudevan AA, Krämer M, Muckenfuss H, Sanzenbacher R, Cichutek K, Flory E, Münk C (2012): Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation status.
J Gen Virol 93: 2425-2430.
Online-Abstract

Kosinska AD, Johrden L, Zhang E, Fiedler M, Mayer A, Wildner O, Lu M, Roggendorf M (2012): DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
J Virol 86: 9297-9310.
Online-Abstract

Krafft H, Bélorgey C, Szalay G (2012): Experience and further development with the Voluntary Harmonization Procedure for multinational clinical trials in the European Union.
Nat Rev Drug Discov 11: 419.
Online-Abstract

Kraus B, Mönk B, Sliva K, Schnierle BS (2012): Expression of Human Endogenous Retrovirus-K Coincides with that of Micro-RNA-663 and -638 in Germ-cell Tumor Cells.
Anticancer Res 32: 4797-4804.
Online-Abstract

Kremer M, Suezer Y, Volz A, Frenz T, Majzoub M, Hanschmann KM, Lehmann MH, Kalinke U, Sutter G (2012): Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
PLoS Pathog 8: e1002557.
Text

Langner JS, Fuchs NV, Hoffmann J, Wittmann A, Brutschy B, Löwer R, Suess B (2012): Biochemical analysis of the complex between the tetrameric export adapter protein Rec of HERV-K/HML-2 and the responsive RNA element RcRE pck30.
J Virol 86: 9079-9087.
Online-Abstract

Leschner S, Deyneko IV, Lienenklaus S, Wolf K, Bloecker H, Bumann D, Loessner H, Weiss S (2012): Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.
Nucleic Acids Res 40: 2984-2994.
Online-Abstract

Lietz R, Bayer W, Ontikatze T, Johrden L, Tenbusch M, Bonsmann MS, Uberla K, Dittmer U, Wildner O (2012): Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
J Virol 3: 1706-1716.
Online-Abstract

Loessner H, Schwantes A, Hamdorf M, Komor U, Leschner S, Weiss S: Employing live microbes for vaccine delivery.
In: von Gabain A, Klade C (Hrsg.), Development of Novel Vaccines. Wien: Springer, 2012. S. 87-124

Mariyanna L, Priyadarshini P, Hofmann-Sieber H, Krepstakies M, Walz N, Grundhoff A, Buchholz F, Hildt E, Hauber J (2012): Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.
PLoS One 7: e31576.
Text

Matheis W, Merkle A (2012): Ausflockungen in Adsorbatimpfstoffen.
Bulletin zur Arzneimittelsicherheit 3: 12-16.
Text

Mentzer D, Keller-Stanislawski B (2012): Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2010.
Bulletin zur Arzneimittelsicherheit 3: 21-29.
Text

Mentzer D, Keller-Stanislawski B (2012): Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2009.
Bulletin zur Arzneimittelsicherheit 3: 17-24.
Text

Mentzer D, Prestel J, Adams O, Gold R, Hartung HP, Hengel H, Kieseier BC, Ludwig WD, Keller-Stanislawski B (2012): Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies.
J Neurol Neurosurg Psychiatry 83: 927-933.
Online-Abstract

Mergel A, Mentzer D, Keller-Stanislawski B (2012): UAW-Meldung durch Patienten - spezielles Internetportal geplant.
Bulletin zur Arzneimittelsicherheit 3: 18-21.
Text

Möker J, Salge-Bartels U, Thiem J (2012): Formation of Glyco-Functionalized Platinum Complexes by Cross-Metathesis and Evaluation of Their Efficacy in Inhibition of Lung Tumor Cell Lines.
J Carbohydrate Chem 31: 702-710.
Online-Abstract

Motitschke A, Jungbäck C: The Quantitative ELISA for Inactivated Newcastle Antigen: Experience Report From an OMCL.
In: Jungbäck C (Hrsg.), Potency Testing of Veterinary Vaccines for Animals: The Way From in Vivo to in Vitro. Basel: Karger, 2012. S. 55-66
(Dev Biol ; 134)

Münk C, Jensen BE, Zielonka J, Häussinger D, Kamp C (2012): Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.
Viruses 4: 3132-3161.
Online-Abstract

Muenthaisong S, Ujhelly O, Polgar Z, Varga E, Ivics Z, Pirity MK, Dinnyes A (2012): Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Exp Cell Res 318: 2482-2489.
Online-Abstract

Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, Schaefer C (2012): A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy.
Vaccine 30: 4445-4452.
Online-Abstract

Pauli G, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H (2012): West-Nil-Virus.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 1024-1043.
Text

Petrakis S, Raskó T, Mátés L, Ivics Z, Izsvák Z, Kouzi-Koliakou K, Koliakos G (2012): Gateway-compatible transposon vector to genetically modify human embryonic kidney and adipose-derived stromal cells.
Biotechnol J 7: 891-897.
Online-Abstract

Pfleiderer M: The bumpy road to vaccine registration: How to overcome regulatory hurdles.
In: von Gabain A, Klade C (Hrsg.), Development of Novel Vaccines - skills, knowledge and translational technologies Wien: Springer, 2012. S. 287-300 ISBN 978-3-7091-0708-9

Pfleiderer M: Die Zulassung von Impfstoffen.
In: Dittmann S (Hrsg.), Handbuch der Impfpraxis Marburg: DGK - Beratung und Vertrieb GmbH, 2012. S. 575-588 ISBN 978-3-9814825-0-8

Plesker R, Schulze H, Schuhmacher A (2012): Gallstones in Slender Lorises (Loris tardigradus).
Journal of Zoo and Wildlife Medicine 43: 473-478.
Online-Abstract

Prestel J (2012): Falldefinition für die progressive multifokale Leukenzephalopathie (PML) nach Therapie mit monoklonalen Antikörpern.
Bulletin zur Arzneimittelsicherheit 3: 14-20.
Text

Quattrocchi S, Ruprecht N, Bönsch C, Bieli S, Zürcher C, Boller K, Kempf C, Ros C (2012): Characterization of the early steps of human parvovirus B19 infection.
J Virol 86: 9274-9284.
Online-Abstract

Raiz J, Damert A, Chira S, Held U, Klawitter S, Hamdorf M, Löwer J, Strätling WH, Löwer R, Schumann GG (2012): The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery.
Nucleic Acids Res 40: 1666-1683.
Online-Abstract

Romberg J, Lang S, Balks E, Kamphuis E, Duchow K, Loos D, Rau H, Motitschke A, Jungbäck C (2012): Potency testing of veterinary vaccines: The way from in vivo to in vitro.
Biologicals 40: 100-106.
Online-Abstract

Schmieder A, Schledzewski K, Michel J, Schönhaar K, Morias Y, Bosschaerts T, Van den Bossche J, Dorny P, Sauer A, Sticht C, Géraud C, Waibler Z, Beschin A, Goerdt S (2012): The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection.
Eur J Immunol 42: 2971-2982.
Online-Abstract

Schülke S (2012): Flagellin Fusionsproteine als neuartige Impfstoffe für die Behandlung schwerer Typ I Allergien.
Lebendige Wissenschaft - Spitzenforschung in der Allergologie: 62-73.

Schweizer M, Cichutek K: Introduction.
In: Cohen-Hagenauer O (Hrsg.), Clinical Gene Transfer - State Of The Art (The CliniBook). Paris: EDK, 2012. S. 127-128

Schweizer M, Cichutek K: Development of SIVsmmPBj vectors for gene transfer into myeloid cells.
In: Cohen-Hagenauer O (Hrsg.), Clinical Gene Transfer - State Of The Art (The CliniBook). Paris: EDK, 2012. S. 134-138

Seitz R, Hilger A, Heiden M (2012): Bone Marrow, Peripheral Blood, or Umbilical Cord Blood: Does the Source of Allogeneic Hematopoietic Progenitor Cells Matter?.
J Blood Disord Transfus S1: 007.
Fulltext

Sliva K, Resch T, Kraus B, Goffinet C, Keppler OT, Schnierle BS (2012): The cellular antiviral restriction factor tetherin does not inhibit poxviral replication.
J Virol 86: 1893-1896.
Online-Abstract

Störmer M, Arroyo A, Brachert J, Carrero H, Devine D, Epstein JS, Gabriel C, Gelber C, Goodrich R, Hanschmann KM, Heath DG, Jacobs MR, Keil S, de Korte D, Lambrecht B, Lee CK, Marcelis J, Marschner S, McDonald C, McGuane S, McKee M, Müller TH, Muthivhi T, Pettersson A, Radziwon P, Ramirez-Arcos S, Reesink HW, Rojo J, Rood I, Schmidt M, Schneider CK, Seifried E, Sicker U, Wendel S, Wood EM, Yomtovian RA, Montag T (2011): Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria.
Vox Sang 102: 22-31.
Online-Abstract

Sun Y, Gruber M, Matsumoto M (2012): Overview of global regulatory toxicology requirements for vaccines and adjuvants.
J Pharmacol Toxicol Methods 65: 49-57.
Online-Abstract

Swierczek M, Izsvák Z, Ivics Z (2012): The Sleeping Beauty transposon system for clinical applications.
Expert Opin Biol Ther 12: 139-153.
Online-Abstract

Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K, Ono SJ (2012): Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk.
J Biol Chem 2887: 24516-24524.
Online-Abstract

Trcka J, Schäd GG, Scheurer S, Conti A, Vieths S, Gross G, Trautmann A (2012): Rice-Induced Anaphylaxis: IgE-Mediated Allergy against a 56-kDa Glycoprotein.
Int Arch Allergy Immunol 158: 9-17.
Online-Abstract

Vieths S, Barber D, Chapman M, Costanzo A, Daas A, Fiebig H, Hanschmann KM, Hrabina M, Kaul S, Ledesma A, Moingeon P, Reese G, Schörner C, van Ree R, Weber B, Buchheit KH (2012): Establishment of Recombinant Major Allergens Bet v 1 and Phl p 5a as European Pharmacopoeia Reference Standards and Validation of ELISA Methods for their Measurement.
Pharmeuropa Bio and Scientific Notes: 118-134.

Vieths S (2012): Allergien.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 55: 301-302.
Text

Vieths S, Kaul S, Hanschmann KM, Schörner C, Barber D, Ledesma A, Chapman M, Hrabina M, Moingeon P, Fiebig H, Reese G, Weber B, van Ree R, Buchheit KH, Constanzo A (2012): Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. Reference standards and validation of ELISA methods for their measurement.
Pharmeur Bio Sci Notes: 118-134.

Voigt K, Gogol-Döring A, Miskey C, Chen W, Cathomen T, Izsvák Z, Ivics Z (2012): Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.
Mol Ther 20: 1852-1862.
Online-Abstract

von Hoven G, Kloft N, Neukirch C, Ebinger S, Bobkiewicz W, Weis S, Boller K, Janda KD, Husmann M (2012): Modulation of translation and induction of autophagy by bacterial exoproducts.
Med Microbiol Immunol 201: 409-418.
Online-Abstract

Wagner R, Göpfert C, Hammann J, Neumann B, Wood J, Newman R, Wallis C, Alex N, Pfleiderer M (2012): Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.
Vaccine 30: 4113-4122.
Online-Abstract

Wagner R, Pfleiderer M (2012): Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency.
Expert Rev Vaccines 11: 881-883.
Online-Abstract

Wagner W, Reuter A, Hüller P, Löwer J, Wessler S (2012): Peroxiredoxin 6 promotes upregulation of the prion protein (PrP) in neuronal cells of prion-infected mice.
Cell Commun Signal 10: 38.
Text

Waibler Z, Seitz R (2012): Wie lassen sich Anti-Drug-Antikörper verhindern? EU-Forschungskonsortium mit Beteiligung des PEI.
Bulletin zur Arzneimittelsicherheit 3: 36-38.
Text

Wangorsch A, Weigand D, Peters S, Mahler V, Fötisch K, Reuter A, Imani J, DeWitt AM, Kogel KH, Lidholm J, Vieths S, Scheurer S (2012): Identification of a Dau c PRPlike protein (Dau c 1.03) as a new allergenic isoform in carrots (cultivar Rodelika).
Clin Exp Allergy 42: 156-166.
Online-Abstract

Weigmann B, Schughart N, Wiebe C, Sudowe S, Lehr HA, Jonuleit H, Vogel L, Becker C, Neurath MF, Grabbe S, Saloga J, Bellinghausen I (2012): Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.
J Allergy Clin Immunol 129: 1126-1135.
Online-Abstract

Weise M, Bielsky MC, De Smet K, Ehmann F, Ekman N, Giezen TJ, Gravanis I, Heim HK, Heinonen E, Ho K, Moreau A, Narayanan G, Kruse NA, Reichmann G, Thorpe R, van Aerts L, Vleminckx C, Wadhwa M, Schneider CK (2012): Biosimilars: what clinicians should know.
Blood 120: 5111-5117.
Online-Abstract

Weiss K, Salzig D, Mühlebach MD, Cichutek K, Pförtner R, Czermak P (2012): Key Parameters of Measles Virus Production for Oncolytic Virotherapy.
Am J Biochem Biotechnol 8: 81-98.
Online-Abstract

Weisser K, Lütkehermölle W (2012): Risikomanagement-System – ein proaktives Instrument der Pharmakovigilanz.
Bulletin zur Arzneimittelsicherheit 3: 25-29.
Text

Weißmüller S, Semmler LY, Kalinke U, Christians S, Müller-Berghaus J, Waibler Z (2012): ICOS-LICOS interaction is critically involved in TGN1412-mediated T cell activation.
Blood 119: 6268-6277.
Online-Abstract

Wenzel UA, Bank E, Florian C, Förster S, Zimara N, Steinacker J, Klinger M, Reiling N, Ritter U, van Zandbergen G (2012): Leishmania major parasite stage-dependent host cell invasion and immune evasion.
FASEB J 26: 29-39.
Online-Abstract

Yu P, Lübben W, Slomka H, Gebler J, Konert M, Cai C, Neubrandt L, Prazeres da Costa O, Paul S, Dehnert S, Döhne K, Thanisch M, Storsberg S, Wiegand L, Kaufmann A, Nain M, Quintanilla-Martinez L, Bettio S, Schnierle BS, Kolesnikova L, Becker S, Schnare M, Bauer S (2012): Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors.
Immunity 37: 867-879.
Online-Abstract

Zabolotneva AA, Bantysh O, Suntsova MV, Efimova N, Malakhova GV, Schumann GG, Gayfullin NM, Buzdin AA (2012): Transcriptional regulation of human-specific SVA(F1) retrotransposons by cis-regulatory MAST2 sequences.
Gene 505: 128-136.
Online-Abstract

Zhou Q, Schneider IC, Edes I, Honegger A, Bach P, Schönfeld K, Schambach A, Wels WS, Kneissl S, Uckert W, Buchholz CJ (2012): T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing.
Blood 120: 4334-4342.
Online-Abstract

This Page